New Research Demonstrates 2.3 Point Reduction in HbA1c for Dario Digital Health Users with Baseline HbA1c Greater Than 9 Points
Retrospective cohort study presented at the American Diabetes Association 83rd Scientific Sessions analyzed real-world data of Dario users against…
Rimidi and ARKRAY Partner to Bring Glucose Data from the GLUCOCARD® Shine Connex Blood Glucose Monitoring System to the EHR
The integration enables providers to manage blood-glucose control more proactively within existing workflows, thus boosting patient adherence Rimidi,…
Leon Medical Centers Partners with Health Tech Company Rimidi, Reducing A1Cs in High-Risk Cohort of Patients with Type 2 Diabetes
84% of patients being remotely monitored by Leon clinicians using Rimidi’s platform have improved their A1C to below 9%…
New Research from DarioHealth Expands Evidence that Personalized Interventions Impact Health Behaviors and Improve User Engagement
New study presented at the American Diabetes Association 81st Scientific Sessions New digital experience increases user engagement by 56%…
DarioHealth Publishes Research Confirming the Impact of a Digital Therapeutic Platform and Live Coaching on Diabetes Outcomes
New Results Further confirm the Relationship Between Personalization and Outcomes DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global…
Fresenius Medical Care North America Selects Tridiuum to Pilot Integrated Behavioral Health Program for People Living With Kidney Disease
Leading kidney care provider launches pilot to proactively identify behavioral health issues that impact patient outcomes and streamline care…